If data continue to support consistent benefit in patients with renal disease, the tide may continue to shift away from first-line use of metformin, and to-ward a strategy that begins with an SGLT2i or GLP1RA
Scientific reports, 9(1), 6274
For researchers who experience significant gastrointestinal side effects , an 8mg maintenance dose delivers nearly equivalent results with better tolerability
How do the outcomes of current oral GLP-1 drugs compare to injectable GLP-1 drugs, in terms of efficacy and side effects
This is a triple-agonist medication that acts on three different hormone receptors in the body: glucagon-like peptide-1 (GLP-1), gastric inhibitory polypeptide (GIP), and glucagon (GCG), Dr
We've been hearing for months about the potential federal cuts